News
Media
Conferences
Resources
Subscribe
CE/CME

Spotlight -

VMS and Menopause|

Atopic Dermatitis Provider Toolkit|

Adult Immunization Provider Toolkit|

Dermatology Hot Topics

Medical Economics Editorial Staff

Articles by Medical Economics Editorial Staff

Medicare Part D Phase 2 Price Negotiations Target Semaglutide (Wegovy) Plus 14 More ©Corona Borealis/stock.adobe.com

Medicare Part D Phase 2 Price Negotiations Target Semaglutide (Wegovy) Plus 14 More Medications

ByMedical Economics Editorial Staff

January 17th 2025

Price negotiations, effective in 2027, cover drugs for diabetes, cancer, COPD, and more, aiming for substantial Medicare savings.

Latest Updated Articles

Trending on Patient Care Online

The Year in Alzheimer Disease: Disease-Modifying Therapies, Regulatory Approvals, and Safety

Caregiver Education on Alzheimer Agitation Is Essential: A Q&A with Geriatric Nurse Practitioner Carolyn Clevenger